Insys Therapeutics Inc. (INSY) Forecast, Price Target & Analyst Ratings

NASDAQ:INSY

0.2911
0 (-1.36%)
At close: Jun 18, 2019
0.255
-0.04 (-12.4%)
After Hours: 6/18/2019, 8:51:28 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Insys Therapeutics Inc. (INSY).

Forecast Snapshot

Consensus Price Target

Price Target
N/A
N/A
 → Price target details

Next Earnings Forecast

Earnings Estimate
Release DateN/A
 → Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
N/A
Upside
N/A
From current price of $0.29 to mean target of N/A, Based on 3 analyst forecasts
Low
N/A
Median
N/A
High
N/A

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

 → Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

INSY Current Analyst RatingINSY Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.2 0.4 0.6 0.8

Analyst Ratings History

INSY Historical Analyst RatingsINSY Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -5 -4 -3 -2 -1 0 1 2 3 4

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
INSY was analyzed by 3 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about INSY.
In the last month the buy percentage rose by 8 points. So the trust of analysts is improving.
Only 3 analysts analyzed INSY. So this is just the average opinion of a couple of analysts.
 → Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release DateN/A

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

 → Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

Insys Therapeutics Inc. / INSY Forecast FAQ

What is the number of analysts for INSY stock?

The number of analysts covering Insys Therapeutics Inc. (INSY) is 3.